Comparing two surgeries for low rectal cancer to protect anal function
Part of Cancer, Digestive system clinical trials.
This trial compares two types of surgery for low rectal cancer to see which one better preserves your ability to control bowel movements. It is for people whose cancer has not spread and who have good anal function before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a diagnosis of moderately or well-differentiated rectal cancer (a less aggressive type).
- Your tumor is low in the rectum (within about 2 inches from the anal opening).
- The tumor is small (3 cm or less, or less than one-third of the bowel wall).
- Your cancer has not spread to other parts of the body.
- You have normal bowel control (no significant leakage or urgency) before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests three different surgical methods for rectal cancer located very close to the anal canal. The goal is to see which method works best in the short and long term while preserving anal function.
This trial compares two surgical techniques to see which one better preserves anal function after surgery for low rectal cancer. If you may be eligible for anal-preserving surgery, it may help your care team choose the approach that best protects bowel control.
This trial tests a combination of chemotherapy and radiation before surgery for people with locally advanced low rectal cancer. The goal is to shrink the tumor enough to avoid removing the anus and keep the rectum intact.
This trial looks at different ways to help bowel and anal function (how well you control gas and stool) in people with rectal cancer who are planning a sphincter-preserving surgery. It may help find an approach that improves quality of life after treatment.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial tests a strategy to avoid surgery by using watchful waiting after initial treatment for early-stage rectal cancer. It may help patients keep their rectum and avoid a permanent colostomy.
Hear when a new Rectum Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.